We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
189 hedge funds and large institutions have $278M invested in Esperion Therapeutics in 2024 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 55 increasing their positions, 44 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
32% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 25
30% more capital invested
Capital invested by funds: $214M → $278M (+$63.6M)
26% more call options, than puts
Call options by funds: $5.22M | Put options by funds: $4.13M
25% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 44
3% more funds holding
Funds holding: 183 → 189 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.91% less ownership
Funds ownership: 66.02% → 64.11% (-1.9%)
Holders
189
Holders Change
+6
Holders Change %
+3.28%
% of All Funds
2.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
33
Increased
55
Reduced
44
Closed
25
Calls
$5.22M
Puts
$4.13M
Net Calls
+$1.09M
Net Calls Change
+$204K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$8.55M |
| 2 |
ICM
Indaba Capital Management
San Francisco,
California
|
+$7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$3.78M |
| 4 |
Goldman Sachs
New York
|
+$3.37M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$2.65M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$6M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$5.1M |
| 3 |
CP
CenterBook Partners
Greenwich,
Connecticut
|
-$4.21M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.25M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.1M |
